This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

NDSee You In 2033: FDA's 12‑Digit NDC Is Coming

The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.

United States Healthcare

AF

ArentFox Schiff

Are You Tracking The Right NSPM-33 Research Security Program Deadline—or Just The Popular One?

Universities that receive more than $50 million in federal research and development funding annually are required to stand up research security programs (RSPs).

United States Healthcare

B

BakerHostetler

OCR Launches Part 2 Civil Enforcement Program

On February 13, the Department of Health and Human Services Office for Civil Rights (OCR) announced a new program to implement and enforce federal requirements...

United States Healthcare

BB

Bass, Berry & Sims

Health-E Law Episode 22: J.P. Morgan Healthcare 2026 And Beyond: Regulation, Technology And The Future Of Health Equity (Podcast)

Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Adam Herbst...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

When Performance Management Meets Age Bias Claims: Lessons From Chreky V. University Of Pittsburgh Physicians

United States Healthcare

KD

Kelley Drye & Warren LLP

CMS CY 2027 Advance Notice Includes Flat Rate Increase And Modified Methodologies

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

8 Things To Know About CMS's Nationwide Moratorium On DMEPOS Medical Supply Companies

United States Healthcare

KM

Katten Muchin Rosenman LLP

FDA Accepts Dr. Reddy's Laboratories' BLA For Abatacept Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

FDA Issues Draft Guidance Clarifying Three-Year New Clinical Investigation Exclusivity

United States Healthcare

AP

Arnold & Porter

Healthcare And Private Equity Transactions Continue To Be Under State Scrutiny

United States Healthcare

B

BakerHostetler

Payers, Providers, And Patients – Oh My!: Organ Procurement Overview & Updates (Podcast)

United States Healthcare

CM

Crowell & Moring LLP

OIG Special Advisory Bulletin Addresses Direct-to-Consumer Prescription Drug Sales And Provides A Framework For Compliant Programs

United States Healthcare

WS

Winston & Strawn LLP

2025 Year In Review: Life Sciences Licensing & Collaboration Deals

United States Healthcare

GP

Goodwin Procter LLP

The Supreme Court's "Skinny Label" Showdown: What Hikma v. Amarin Means For Generic Drug Companies

United States Healthcare

UT

Upadhye Tang

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

NDSee You In 2033: FDA's 12‑Digit NDC Is Coming

The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.

United States Healthcare

AF

ArentFox Schiff

Are You Tracking The Right NSPM-33 Research Security Program Deadline—or Just The Popular One?

Universities that receive more than $50 million in federal research and development funding annually are required to stand up research security programs (RSPs).

United States Healthcare

B

BakerHostetler

CMS CY 2027 Advance Notice Includes Flat Rate Increase And Modified Methodologies

On January 26, 2026, CMS released the Advance Notice of Methodological Changes for Calendar Year ("CY") 2027 for Medicare Advantage ("MA") Capitation Rate and Part C and Part D Payment Policies...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA Issues Draft Guidance Clarifying Three-Year New Clinical Investigation Exclusivity

United States Healthcare

AP

Arnold & Porter

OIG Special Advisory Bulletin Addresses Direct-to-Consumer Prescription Drug Sales And Provides A Framework For Compliant Programs

United States Healthcare

WS

Winston & Strawn LLP

The Supreme Court's "Skinny Label" Showdown: What Hikma v. Amarin Means For Generic Drug Companies

United States Healthcare

UT

Upadhye Tang

The Learned Concierge - March 2026, Vol. 28

United States Healthcare

CH

Clark Hill

Fifth Circuit Adopts Narrow Interpretation Of Two Critical DEA Regulations

United States Healthcare

GP

Goodwin Procter LLP

FDA Announces A Single Pivotal Trial As The New Default Standard For Drug Approval

United States Healthcare

AF

ArentFox Schiff

See more

Life Sciences, Biotechnology & Nanotechnology

NDSee You In 2033: FDA's 12‑Digit NDC Is Coming

The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.

United States Healthcare

AF

ArentFox Schiff

Are You Tracking The Right NSPM-33 Research Security Program Deadline—or Just The Popular One?

Universities that receive more than $50 million in federal research and development funding annually are required to stand up research security programs (RSPs).

United States Healthcare

B

BakerHostetler

FDA Accepts Dr. Reddy's Laboratories' BLA For Abatacept Biosimilar

Dr. Reddy's Laboratories ("Dr. Reddy's") announced on February 22 that the FDA accepted its BLA for DRL_AB, a proposed interchangeable biosimilar to Bristol-Myers Squibb's ORENCIA® (abatacept) IV for infusion.

United States Healthcare

GP

Goodwin Procter LLP

2025 Year In Review: Life Sciences Licensing & Collaboration Deals

United States Healthcare

GP

Goodwin Procter LLP

New Referral To The Enlarged Board Of Appeal Expected Regarding Claim Interpretation In The Context Of Added Subject Matter

United States IP

JA

J A Kemp LLP

FDA Announces A Single Pivotal Trial As The New Default Standard For Drug Approval

United States Healthcare

AF

ArentFox Schiff

Janssen Files BPCIA Complaint Against Bio-Thera And Accord Related To Golimumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

European Biosimilar Updates

United States Healthcare

GP

Goodwin Procter LLP

Florida AG Forms CHINA Unit Focused On Foreign Data Threats

United States Healthcare

FL

Foley & Lardner

See more

Healthcare

NDSee You In 2033: FDA's 12‑Digit NDC Is Coming

The US Food and Drug Administration (FDA) issued a final rule on March 5 that will change National Drug Codes (NDCs) from several different 10‑digit formats to one standard 12‑digit format.

United States Healthcare

AF

ArentFox Schiff

OCR Launches Part 2 Civil Enforcement Program

On February 13, the Department of Health and Human Services Office for Civil Rights (OCR) announced a new program to implement and enforce federal requirements...

United States Healthcare

BB

Bass, Berry & Sims

Health-E Law Episode 22: J.P. Morgan Healthcare 2026 And Beyond: Regulation, Technology And The Future Of Health Equity (Podcast)

Welcome to Health-e Law, Sheppard's podcast exploring the fascinating health tech topics and trends of the day. In this episode, partner and host Michael Orlando welcomes Adam Herbst...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

When Performance Management Meets Age Bias Claims: Lessons From Chreky V. University Of Pittsburgh Physicians

United States Healthcare

KD

Kelley Drye & Warren LLP

CMS CY 2027 Advance Notice Includes Flat Rate Increase And Modified Methodologies

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

8 Things To Know About CMS's Nationwide Moratorium On DMEPOS Medical Supply Companies

United States Healthcare

KM

Katten Muchin Rosenman LLP

Fifth Circuit Decision In Health Care Fraud Case Highlights Importance Of Careful Drafting In Civil RICO Complaints

United States Criminal

CM

Crowell & Moring LLP

Healthcare And Private Equity Transactions Continue To Be Under State Scrutiny

United States Healthcare

B

BakerHostetler

Payers, Providers, And Patients – Oh My!: Organ Procurement Overview & Updates (Podcast)

United States Healthcare

CM

Crowell & Moring LLP

See more

Latest Videos

See more

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Video)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Repair, Refocus, Reimagine: Michele Volpe Leads Penn Medicine To Sustainable Growth (Video)

AM

Alvarez & Marsal

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Upcoming Events

Marsh Health Tech Symposium

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Pharmaceutical Compliance Congress 2026

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

AHLA’s Institute On Medicare and Medicaid Payment Issues Registration

United States Healthcare

FH

Foley Hoag LLP

Medicare Advantage Fraud Enforcement Under A New Administration: Mitigating Risk For Criminal And Civil Actions

United States Healthcare

M

Mintz

MassBio State Of Possible Conference

United States Healthcare

FH

Foley Hoag LLP

New CMS Rural Health Transformation Program: Purpose, Funding Eligibility And Allocation, Healthcare Provider Impact

United States Healthcare

FH

Foley Hoag LLP

AHLA Health Care Transactions Program 2026

United States Healthcare

AV

Axinn Veltrop & Harkrider

Institute On Medicare And Medicaid Payment Issues

United States Healthcare

FL

Foley & Lardner

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More